IFNG 6-gene signature

News alerts, weekly reports and conference planners

IFNG 6-gene signature	Gastric Cancer	IFNG 6-gene signature	Gastric Cancer	pembrolizumab Sensitive: C3 – Early Trials pembrolizumab Sensitive : C3	pembrolizumab Sensitive: C3 – Early Trials pembrolizumab Sensitive : C3
IFNG 6-gene signature	Head and Neck Cancer	IFNG 6-gene signature	Head and Neck Cancer	pembrolizumab Sensitive: C3 – Early Trials pembrolizumab Sensitive : C3	pembrolizumab Sensitive: C3 – Early Trials pembrolizumab Sensitive : C3
IFNG 6-gene signature	Gastroesophageal Junction Adenocarcinoma	IFNG 6-gene signature	Gastroesophageal Junction Adenocarcinoma	tislelizumab Sensitive: C3 – Early Trials tislelizumab Sensitive : C3	tislelizumab Sensitive: C3 – Early Trials tislelizumab Sensitive : C3

Associations